(Q37308694)

19 August 2017

Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma (English)

1 reference

19 August 2017

Paulette Mhawech-Fauceglia

1

1 reference

19 August 2017

Dan Wang

2

1 reference

19 August 2017

Damanzoopinder Samrao

3

1 reference

19 August 2017

Heidi Godoy

4

1 reference

19 August 2017

Faith Ough

5

1 reference

19 August 2017

Song Liu

6

1 reference

19 August 2017

Tanja Pejovic

7

1 reference

19 August 2017

Shashikant Lele

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

15 June 2012

1 reference

19 August 2017

1 reference

19 August 2017

127

1 reference

19 August 2017

1

1 reference

19 August 2017

198-201

1 reference

Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

A comprehensive analysis of PAX8 expression in human epithelial tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

Transcriptional control of kidney development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

Tissue microarrays for high-throughput molecular profiling of tumor specimens

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5049509

2 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.012

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.012

Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.012

Grading ovarian serous carcinoma using a two-tier system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.012

Pax-8 is a reliable marker in making the diagnosis in advanced stage epithelial ovarian carcinoma and primary peritoneal carcinoma for neoadjuvant chemotherapy on cell block and biopsy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.012

Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22705448

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2012.06.012

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

22705448

1 reference